ATE434446T1 - Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität - Google Patents

Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität

Info

Publication number
ATE434446T1
ATE434446T1 AT04741321T AT04741321T ATE434446T1 AT E434446 T1 ATE434446 T1 AT E434446T1 AT 04741321 T AT04741321 T AT 04741321T AT 04741321 T AT04741321 T AT 04741321T AT E434446 T1 ATE434446 T1 AT E434446T1
Authority
AT
Austria
Prior art keywords
compound
receptor affinity
active substance
substance combination
npy
Prior art date
Application number
AT04741321T
Other languages
English (en)
Inventor
Jover Torrens
Prio Josep Mas
Zueras Alberto Dordal
Soler Xavier Codony
Vidal Ramon Merce
Castrillo Perez Jose Aurelio
Constansa Jordi Frigola
Helmut-Heinrich Buschmann
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE434446T1 publication Critical patent/ATE434446T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
AT04741321T 2003-07-30 2004-07-29 Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität ATE434446T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301815A ES2228268B1 (es) 2003-07-30 2003-07-30 Combinacion de sustancias activas conteniendo al menos un compuesto con afinidad por el receptor del neuropeptido y (npy) y al menos un compuesto con afinidad por el receptor 5-ht6.
PCT/EP2004/008514 WO2005014045A1 (en) 2003-07-30 2004-07-29 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity

Publications (1)

Publication Number Publication Date
ATE434446T1 true ATE434446T1 (de) 2009-07-15

Family

ID=34130548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741321T ATE434446T1 (de) 2003-07-30 2004-07-29 Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität

Country Status (9)

Country Link
US (1) US20070009597A1 (de)
EP (1) EP1660131B1 (de)
AT (1) ATE434446T1 (de)
AU (1) AU2004262488A1 (de)
CA (1) CA2534099A1 (de)
DE (1) DE602004021704D1 (de)
ES (2) ES2228268B1 (de)
MX (1) MXPA06001230A (de)
WO (1) WO2005014045A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1771169A1 (de) 2004-07-14 2007-04-11 PTC Therapeutics, Inc. Verfahren zur behandlung von hepatitis c
WO2007098418A1 (en) 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-ht6 receptor affinity
WO2007147883A1 (en) * 2006-06-23 2007-12-27 Laboratorios Del Dr. Esteve, S.A. Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
EP1953153A1 (de) 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Heterocyclyl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen bzw. Ernährungserkrankungen
EP1953141A1 (de) * 2007-01-31 2008-08-06 Laboratorios del Dr. Esteve S.A. Aryl-substituierte Sulfonamide für die Behandlung von Wahrnehmungsstörungen oder Ernährungskrankheiten
EP2053052A1 (de) 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Verfahren zur Herstellung von 6-substituiertem Imidazo[2,1-b]thiazol-5-sulfonylhalogenid
PT3860998T (pt) 2018-10-05 2024-04-02 Annapurna Bio Inc Compostos e composições para o tratamento de condições associadas à atividade do recetor apj
WO2023044556A1 (en) * 2021-09-24 2023-03-30 Enveric Biosciences Canada Inc. Aminated psilocybin derivatives and methods of using

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2073301T3 (es) * 1991-05-20 1995-08-01 Marion Laboratories Inc Composicion multi-capa de liberacion controlada.
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
WO1997035881A2 (en) * 1996-03-27 1997-10-02 Ng Gordon Y K Receptor and transporter antagonists
KR100889718B1 (ko) * 2001-06-11 2009-03-23 바이오비트럼 에이비(피유비엘) 치환 술폰아미드 화합물, ｃｎｓ 장애, 비만 및 ⅱ 형당뇨병 치료용 약제로서의 이들의 사용 방법
DE60232173D1 (de) * 2001-11-09 2009-06-10 Biovitrum Ab Publ Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme
ES2187300B1 (es) * 2001-11-14 2004-06-16 Laboratorios Del Dr. Esteve, S.A. Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.

Also Published As

Publication number Publication date
DE602004021704D1 (de) 2009-08-06
ES2228268B1 (es) 2006-07-01
ES2228268A1 (es) 2005-04-01
MXPA06001230A (es) 2006-05-15
EP1660131A1 (de) 2006-05-31
WO2005014045A1 (en) 2005-02-17
AU2004262488A1 (en) 2005-02-17
EP1660131B1 (de) 2009-06-24
ES2328485T3 (es) 2009-11-13
CA2534099A1 (en) 2005-02-17
US20070009597A1 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
BRPI0411699A (pt) compostos para uso como substáncia terapeuticamente ativa; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação de receptores cb1 e uso destes compostos
EA200301213A1 (ru) Лиганды рецепторов 5-ht и их применение
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
NO20034289D0 (no) N-(2-aryletylbenzylaminer som antagonister av 5-HT6- reseptoren
DE60212163D1 (de) Kontrolliertes wirkstoffabgabesystem
ATE470662T1 (de) Piperazinylpyrazinverbindungen als agonisten oder antagonisten am serotonin-5ht-2-rezeptor
PL363168A1 (pl) Cyklopentanole, kompozycje zawierające takie związki i sposoby leczenia
DK1300398T3 (da) Propan-1,3-dionderivat
ATE413388T1 (de) Muskarin antagonisten
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
ID26055A (id) Senyawa-senyawa hidroksidifenil eter
ATE279861T1 (de) Wirkstoffkombinationen mit insektiziden und akariziden eigenschaften
HRP20050510A2 (en) Microbicide substances
BR9909486A (pt) Compostos calcilìticos
SE9901077D0 (sv) Novel use
DE602004021704D1 (de) Wirksubstanzkombination mit einer verbindung mit npy rezeptor-affinität und einer verbindung mit 5-ht6 rezeptor-affinität
ATE409040T1 (de) Kombination enthaltend substanzen mit npy- rezeptor affinität und substanzen mit 5-ht6- rezeptor affinität
EA201101119A1 (ru) Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
BR9914736A (pt) Compostos de 3-(fenil substituìdo)-5-tienil-1,2,4-triazol com atividade contra mosca branca
TR199901017A2 (xx) B�cek ilac� terkibi.
BR0109364A (pt) Métodos para fabricação de citalopram através de alquilação escalonada de 5-substituìda 1- (4-fluorofenil) - 1,3- diidroisobenzofuranos e citalopram
ATE407133T1 (de) 2-imidazo-benzothiazole als adenosin-rezeptor liganden
ES2183709B1 (es) Composicion para el control de artropodos.
DE60139770D1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties